Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ClearPoint Neuro Inc.

    NASDAQ: CLPT · Real-Time Price · USD
    14.12
    -0.13 (-0.91%)
    At close: May 09, 2025, 3:59 PM
    14.15
    0.21%
    After-hours: May 09, 2025, 04:58 PM EDT
    -0.91%
    Bid 13.3
    Market Cap 395.07M
    Revenue (ttm) 31.39M
    Net Income (ttm) -18.91M
    EPS (ttm) -0.7
    PE Ratio (ttm) -20.17
    Forward PE -20.42
    Analyst Strong Buy
    Ask 15
    Volume 181,727
    Avg. Volume (20D) 249,649
    Open 14.26
    Previous Close 14.25
    Day's Range 14.10 - 14.78
    52-Week Range 5.11 - 19.22
    Beta 1.04

    About CLPT

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CLPT
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CLPT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    ClearPoint Neuro Inc. is scheduled to release its earnings on May 13, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +10.09%
    ClearPoint Neuro shares are trading higher after S... Unlock content with Pro Subscription
    2 months ago
    -17.48%
    ClearPoint Neuro shares are trading lower after the company reported worse-than-expected Q4 financial results.
    news image

    1 week ago · seekingalpha.com

    ClearPoint Neuro: Fundamentals Continue To Strengthen

    ClearPoint continues to make progress in relation to its LITT and operating room expansion efforts. More importantly, ClearPoint's partners continue to provide positive news in relation to their thera...

    news image

    2 weeks ago · accessnewswire.com

    ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

    SOLANA BEACH, CA / ACCESS Newswire / April 25, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the ...

    news image

    2 months ago · seekingalpha.com

    ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen

    ClearPoint's Q4 results were soft, although lumpy growth should be expected given the nature of ClearPoint's business. Neurosurgery growth remains robust, and the expansion of preclinical and clinical...

    news image

    2 months ago · seekingalpha.com

    ClearPoint Neuro, Inc. (CLPT) Q4 2024 Earnings Call Transcript

    ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Alessandro - CFO Conference Call Participants Frank ...

    news image

    2 months ago · zacks.com

    ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Misses Revenue Estimates

    ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.19 per share a year ago.

    news image

    2 months ago · accessnewswire.com

    ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

    Achieved Record Revenue for 2024 and Growth of 31%; Reduced 2024 Operational Cash Burn by 35% SOLANA BEACH, CALIFORNIA / ACCESS Newswire / February 26, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the...

    news image

    2 months ago · accessnewswire.com

    ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

    SOLANA BEACH, CA / ACCESS Newswire / February 14, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to t...

    news image

    2 months ago · accessnewswire.com

    ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

    SOLANA BEACH, CA / ACCESS Newswire / February 12, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to t...

    Add to Watchlist